Manufacturing and Production Costs
Ivermectin is a semi-synthetic compound derived from fermentation processes. Producing it requires specialized facilities, strict quality control, and regulatory compliance, which raises manufacturing expenses. These costs are passed on to buyers through wholesale and retail pricing.
Supply Chain and Distribution
Global distribution networks add layers of logistics, storage, and handling costs. Ivermectin must be stored under specific conditions and shipped through regulated channels. Limited production capacity in some regions can also create supply constraints that influence price levels.
Regulatory and Market Factors
Regulatory approvals, patent protections, and market demand affect pricing structures. In some countries, ivermectin is available as a low-cost generic, while in others, branded versions or limited competition keep prices higher. Changes in demand, such as during public health discussions, can also temporarily affect availability and cost.
For more on drug pricing trends, see WHO Essential Medicines.
